Burcon NutraScience Corporation
BU.TO · TSX
3/31/2025 | 3/31/2024 | 3/31/2023 | 3/31/2022 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | -0.00 | 2.62 | -0.35 | -0.34 |
| FCF Yield | -39.15% | -0.42% | -0.54% | -0.14% |
| EV / EBITDA | -4.03 | -226.39 | -62.31 | -520.11 |
| Quality | ||||
| ROIC | -26.24% | -61.90% | -80.55% | -26.12% |
| Gross Margin | -228.31% | 100.00% | 100.00% | 100.00% |
| Cash Conversion Ratio | 0.67 | 0.78 | 0.24 | 0.58 |
| Growth | ||||
| Revenue 3-Year CAGR | 1.58% | 2.45% | 12.05% | 76.60% |
| Free Cash Flow Growth | 1.49% | 7.39% | 11.23% | -21.61% |
| Safety | ||||
| Net Debt / EBITDA | -2.03 | -0.40 | -0.20 | 0.70 |
| Interest Coverage | -11.51 | -14.62 | -25.14 | -65.19 |
| Efficiency | ||||
| Inventory Turnover | 6.23 | 0.00 | 0.00 | 0.00 |
| Cash Conversion Cycle | -207.12 | 266.50 | 333.11 | 426.46 |